share_log

藥明生物：致非登記股東之信函及回條 - 以電子方式發布公司通訊之安排

WUXI BIO: Notification Letter and Reply Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications

香港交易所 ·  Mar 27 16:02
Summary by Futu AI
药明生物於2024年3月27日宣布，根據香港聯合交易所有限公司證券上市規則的修訂，自2023年12月31日起，公司將採用全新的電子方式發佈公司通訊。未來，公司通訊的中英文版本將不再郵寄印刷本給非登記股東，除非有特別要求。所有公司通訊將可在药明生物官方網站及聯交所網站上電子形式獲取。公司不會另行通知股東有關網站版本的公司通訊發布情況，鼓勵股東主動上網查閱。若股東希望收取印刷版公司通訊，需填寫申請表格並聯繫公司的香港股份過戶登記分處卓佳證券登記有限公司。此外，股東提供個人資料是自願性質，用於接收公司通訊。
药明生物於2024年3月27日宣布，根據香港聯合交易所有限公司證券上市規則的修訂，自2023年12月31日起，公司將採用全新的電子方式發佈公司通訊。未來，公司通訊的中英文版本將不再郵寄印刷本給非登記股東，除非有特別要求。所有公司通訊將可在药明生物官方網站及聯交所網站上電子形式獲取。公司不會另行通知股東有關網站版本的公司通訊發布情況，鼓勵股東主動上網查閱。若股東希望收取印刷版公司通訊，需填寫申請表格並聯繫公司的香港股份過戶登記分處卓佳證券登記有限公司。此外，股東提供個人資料是自願性質，用於接收公司通訊。
PHARMACEUTICAL BIOTECH ANNOUNCED ON 27 MARCH 2024 THAT THE COMPANY WILL USE A NEW ELECTRONIC MEANS OF PUBLISHING COMPANY NEWSLETTERS FROM 31 DECEMBER 2023, PURSUANT TO THE AMENDMENTS TO THE LISTING RULES OF THE STOCK EXCHANGE OF HONG KONG STOCK EXCHANGE LIMITED. In the future, the Chinese-English version of the Company's Newsletter will no longer be mailed to non-registered shareholders, unless specifically requested. All company newsletters will be available in electronic form on the official website of Pharmacobiology and on the exchange website. The Company does not notify shareholders of the publication of the Company's newsletter regarding the version of the Website. We encourage shareholders to actively access the Internet. If shareholders wish to receive printed company newsletters, they should fill in the application form and contact the company's Hong Kong Share Transfer Register Office, Chujia Securities Registration Limited. In addition, the provision of personal data by shareholders is voluntary for the purpose of receiving company communications.
PHARMACEUTICAL BIOTECH ANNOUNCED ON 27 MARCH 2024 THAT THE COMPANY WILL USE A NEW ELECTRONIC MEANS OF PUBLISHING COMPANY NEWSLETTERS FROM 31 DECEMBER 2023, PURSUANT TO THE AMENDMENTS TO THE LISTING RULES OF THE STOCK EXCHANGE OF HONG KONG STOCK EXCHANGE LIMITED. In the future, the Chinese-English version of the Company's Newsletter will no longer be mailed to non-registered shareholders, unless specifically requested. All company newsletters will be available in electronic form on the official website of Pharmacobiology and on the exchange website. The Company does not notify shareholders of the publication of the Company's newsletter regarding the version of the Website. We encourage shareholders to actively access the Internet. If shareholders wish to receive printed company newsletters, they should fill in the application form and contact the company's Hong Kong Share Transfer Register Office, Chujia Securities Registration Limited. In addition, the provision of personal data by shareholders is voluntary for the purpose of receiving company communications.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.